ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

Dieser Datensatz wurde verworfen!DetailsÜbersicht

ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.

Athreya, A. P., Neavin, D., Carrillo-Roa, T., Frye, M. A., Skime, M., Rush, A., et al. (2019). ARTIFICIAL-INTELLIGENCE-AUGMENTED PSYCHIATRY WITH PHARMACOGENOMICS: TOWARDS INDIVIDUALIZATION OF ANTIDEPRESSANT SELECTION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. CLINICAL PHARMACOLOGY & THERAPEUTICS, 105, S24-S24.

Item is Verworfen

Basisdaten (Verworfen)

Datum des Verwerfens: 2023-07-24

Kommentar: Doublette

Urheber:
Athreya, A. P.
Neavin, D.
Carrillo-Roa, T.¹
Frye, M. A.
Skime, M.
Rush, A.
Bobo, W. V.
Wang, L.
Binder, E.¹
Iyer, R. K.
Weinshilboum, R. M.

Affiliations:
1Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society, ou_2035295

Datum: Erschienen: 2019

Dateien: 0 Dateien

Externe Referenzen: 0 ext. Referenzen

Versions ID: item_3346284_1

Status des Datensatzes: Verworfen

Name des Kontextes: Publications of the Max Planck Institute of Psychiatry, Zugehörig zu: Max Planck Institute of Psychiatry